knowledge -WSS

knowledge

author：entertainment 2025-09-30 00:47:08 - browse：23677

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Unicorn down: Following layoffs, Biofourmis CEO quietly departs

WSS

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Health insurers say they are turning to AI to cut costs, improve care

AI used to predict Covid

How to make AI work for medicine

David Sabatini, ex

AstraZeneca bets AAV gene therapy will still deliver the goods

hotspot

knowledge

knowledge

23andMe had bad news about my health. I wish a person had delivered it

First Opinion Podcast: What happens when kids become caregivers?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Winners, losers from Medicare’s list of drugs subject to price talks

New air purifier tech could be key to improving indoor air quality

Stigma and the return of syphilis

23andMe had bad news about my health. I wish a person had delivered it

AI used to predict Covid

As demand for Covid shots wanes, Moderna seeks its next success

How to make Best Hospitals ratings actually useful for patients

hotspot

What do new weight loss drugs mean for bariatric surgery?

How a symptom of dementia informs our understanding of creativity

Adam's Biotech Scorecard: Do Sarepta's exon

AstraZeneca challenges Medicare drug negotiation program

Winners, losers from Medicare’s list of drugs subject to price talks

NYU Langone launches private ChatGPT for its health care data

hotspot

explore

entertainment

hotspot